Blueprint Medicines Corporation
Medicines for systemic mastocytosis, allergic diseases and cancer
Visit website ContactClaim & upgrade this listingContact details are protected Something wrong? Suggest a correction
Blueprint Medicines develops and commercializes medicines for patients with systemic mastocytosis, allergic and inflammatory diseases, and cancer. Its approved medicine, avapritinib, treats specified adult mastocytosis and gastrointestinal stromal tumor populations, while its pipeline includes additional therapies under development.
At a Glance
Blueprint Medicines Corporation is an American manufacturer based in Cambridge, MA.
- Where
- Cambridge, MA
